Litigation Details for NOVO NORDISK INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2014)

NOVO NORDISK INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2014)

Docket		Date Filed	2014-07-03
Court	District Court, D. New Jersey	Date Terminated	2015-05-21
Cause	35:271 Patent Infringement	Assigned To	Michael Andre Shipp
Jury Demand	None	Referred To	Douglas Arpert
Parties	TEVA PHARMACEUTICALS USA, INC.
Patents	7,018,992
Attorneys	CHARLES H. CHEVALIER
Link to Docket	External link to docket

Details for NOVO NORDISK INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2014)

Date Filed	Document No.	Description	Snippet	Link To Document
2014-07-03	1		of United States Patent No. 7,018,992 (“the ‘992 patent”) and United States Patent No. 5,860,946 (“the… COUNT FOR INFRINGEMENT OF U.S. PATENT NO. 7,018,992 15. Plaintiffs re-allege… 1. This is an action for patent infringement under the patent laws of the United States, Title… THE PATENTS-IN-SUIT 8. On March 28, 2006, the United States Patent and Trademark… 1999, the United States Patent and Trademark Office issued the ‘946 patent, entitled “Instrument for	External link to document
2014-07-23	7		expiration of U.S. Patent Nos. 7,018,992 (“the ‘992 patent”) and 5,860,946 (“the ‘946 patent”). The remaining…claims of U.S. Patent Nos. 7,018,992 (“the ‘992 patent”) and 5,860,946 (“the ‘946 patent”) are invalid… COUNT FOR INFRINGEMENT OF U.S. PATENT NO. 7,018,992 15. Teva incorporates each…purports to state an action for patent infringement under the patent laws of the United States, Title… THE PATENTS-IN-SUIT 8. Teva admits that according to the face of the ‘992 patent, the	External link to document